JB Chemicals & Pharmaceuticals Limited — Board Meeting, 11-11-2025: Outcome of Board Meeting
11-11-2025 | 05:06 pm
11-11-2025 | 05:06 pm
JB Pharma's board approved the financial results for the quarter and half-year. Consolidated Q2 revenue hit ₹1,084.90 Cr, net profit ₹207.82 Cr. The CCI has cleared Torrent Pharma's acquisition, leading to a merger with a 51:100 share swap ratio.
No comments yet. Be the first to comment!
All announcements from JB Chemicals & Pharmaceuticals Limited
